'Corrective' measures ordered, but Health Canada says 2nd MDMA trial can continue
Health Canada has completed its review of all active trials for MDMA-assisted psychotherapy, suspending one study because of patient safety concerns, but allowing the other to proceed with some 'corrective and preventive' changes.
Comments
Post a Comment